Lung Cancer Trials Ask AI to find trials
CompletedNot applicableNCT03207594
Official study title

Improving Evidence-Based Care for Cancer Patients

Study summary

The purpose of this study is to improve cancer care and the delivery of cancer care. Researchers are interested in studying patient reported information and examining how different factors may impact cancer care.

Ask AI to explain this study
Start here

Key things to know

Main goalNot specified

This describes the study’s primary purpose.

What is being studiedSurvey and Saliva sample

Plus 1 other study approaches.

Who it may be forHead and Neck Cancer · Prostate Cancer

These are broad labels—not an eligibility decision.

Checked against the public recordLast updated Jan 31, 2025 · Source: ClinicalTrials.gov

Is enrollment open?Completed

Ask the study team to confirm whether enrollment is open.

What kind of study?Not applicable

Observational

Where is it offered?1 U.S. location

Locations may change over time.

Who runs it?Medical University of South Carolina

Study sponsor

01
Study overview

What this study is about

Purpose
Not specified
Study type
Observational
Phase
Not applicable
Sponsor
Medical University of South Carolina
Interventions being studied
Other: Survey; Other: Saliva sample; Other: Smoking Status questions
02
Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

03
Public criteria

Who may be able to participate

The sponsor separates these requirements into two groups. You do not need to interpret them alone—use them to guide a conversation with the study team.

Requirements people may need to meetInclusion criteria
  • Diagnosed with head/neck, lung, breast, prostate, gastrointestinal or gynecologic cancer
  • 21 years of age or older at time of study registration
  • Must have been referred to MUSC radiation oncology for treatment with curative radiation therapy
  • Must report current smoking defined as self-reporting smoking within the past 30 days using a structured intake questionnaire.
Reasons someone may not be able to joinExclusion criteria
  • Patients with primary central nervous system malignancies will be excluded.
  • Patients that have other cancer disease types will be excluded due to either significant differences in standard radiation therapy approaches or rarity of disease required radiation.
  • Patients who are currently participating in the Medical University of South Carolina Hollings Cancer Center smoking cessation program
  • Patients who are unable to provide informed consent

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

04
Study sites

U.S. locations

  • Medical University of South CarolinaCharleston, South Carolina

Source and freshness
Processed from ClinicalTrials.gov. Last public update: Jan 31, 2025. Always confirm current availability with the study team.

View original record ↗